Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03151564 · ClinicalTrials.gov registry record · NA
Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques
A NA study of Colorectal Carcinoma and Liver Metastases, sponsored by M.D. Anderson Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 146
- Enrollment target
- 1
- Study location
NCT03151564 is a NA study of Colorectal Carcinoma and Liver Metastases that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 146 participants, below the 1,094-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03151564, a NA study of Colorectal Carcinoma and Liver Metastases, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 146 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare 2 different image creation/processing techniques during a standard CT scan in order to "see" problems in the liver and learn which method provides better image quality. The techniques use new artificial intelligence software to decrease image noise, which helps the radiologist to evaluate.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Computed Tomography Scan - 50% Dose Reduction
- DIAGNOSTIC_TEST Computed Tomography Scan - 70% Dose Reduction
- DIAGNOSTIC_TEST Deep Learning Image Reconstruction (DLIR)
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2017-05-09 |
| Est. Completion | 2027-04-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03151564
The ClinicalTrials.gov registry entry for NCT03151564 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,094-participant average among 53 other Colorectal Carcinoma trials with a reported enrollment target (87% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Colorectal Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Computed Tomography Scan - 50% Dose Reduction is the first listed.
NCT03151564 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03151564 about?
NCT03151564 is a clinical study titled "Lesion Detection Assessment in the Liver: Standard vs Low Radiation Dose Using Varied Post-Processing Techniques". To compare 2 different image creation/processing techniques during a standard CT scan in order to "see" problems in the liver and learn which method provides better image quality. The techniques use new artificial intelligence software to decrease image noise, which helps the radiologist to evaluate...
What is the current status of trial NCT03151564?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 146 participants. The study started on 2017-05-09. Estimated completion is 2027-04-30.
What conditions does trial NCT03151564 study?
This clinical trial studies the following conditions: Colorectal Carcinoma, Liver Metastases, Colon Carcinoma, Diseases of Liver.
What interventions are being tested in trial NCT03151564?
The interventions under investigation include: Computed Tomography Scan - 50% Dose Reduction (DIAGNOSTIC_TEST), Computed Tomography Scan - 70% Dose Reduction (DIAGNOSTIC_TEST), Deep Learning Image Reconstruction (DLIR) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03151564?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03151564 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Implementation of a ColoRectal Cancer Screening Tool in US Primary Care Practices - Usual Quality Improvement (10 Clinics) vs Normalization Process Theory-Participatory Learning in Action (10 Clinics)
RECRUITING · NA
-
Confronting Cancer as a Community
RECRUITING · NA
-
CoGENES Randomized Controlled Trial (RCT)
RECRUITING · NA
-
Improving Colonoscopy Surveillance for Patients With High Risk Colon Polyps
RECRUITING · NA
-
A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
RECRUITING · NA
-
Culturally Adapting an Intervention to Increase Genetic Testing in African American Cancer Survivors
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.